Cargando…

Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes

INTRODUCTION: Identification of novel therapeutics and risk assessment in early stages of Alzheimer's disease (AD) is a crucial aspect of addressing this complex disease. We characterized gene‐expression patterns at the mild cognitive impairment (MCI) stage to identify critical mRNA measures an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bharthur Sanjay, Apoorva, Patania, Alice, Yan, Xiaoran, Svaldi, Diana, Duran, Tugce, Shah, Niraj, Nemes, Sara, Chen, Eric, Apostolova, Liana G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078657/ https://www.ncbi.nlm.nih.gov/pubmed/35142026 http://dx.doi.org/10.1002/alz.12587

Ejemplares similares

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
por: Stage, Eddie, et al.
Publicado: (2021)

Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke
por: Aamodt, Eva Birgitte, et al.
Publicado: (2021)

Neuroimaging Measures as Endophenotypes in Alzheimer's Disease
por: Braskie, Meredith N., et al.
Publicado: (2011)

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis
por: Stage, Eddie C., et al.
Publicado: (2020)

Neuroimaging candidate endophenotypes of social anxiety disorder
por: Yang, Xiyue, et al.
Publicado: (2021)

Determinants of Schizophrenia Endophenotypes Based on Neuroimaging and Biochemical Parameters
por: Bryll, Amira, et al.
Publicado: (2021)

A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease
por: Johnson, Leigh A., et al.
Publicado: (2013)

Neuroimaging of Goal-Directed Behavior in Midlife Women
por: Bosak, Kelly, et al.
Publicado: (2014)

Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
por: Lampert, Erika J., et al.
Publicado: (2013)

Role of Neuroimaging in COVID 19 Infection—A Retrospective Study
por: Kalekar, Tushar, et al.
Publicado: (2021)

Predicting mild cognitive impairment from spontaneous spoken utterances
por: Asgari, Meysam, et al.
Publicado: (2017)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
por: Espinosa, Ana, et al.
Publicado: (2018)

General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women
por: Petkus, Andrew J., et al.
Publicado: (2019)

Neural and behavioral substrates of disorientation in mild cognitive impairment and Alzheimer's disease
por: Sousa, Amber, et al.
Publicado: (2015)

Health Literacy Risk in Older Adults With and Without Mild Cognitive Impairment
por: Liu, Yong B., et al.
Publicado: (2019)

Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager‐horticulturalists
por: Gatz, Margaret, et al.
Publicado: (2022)

Genetic and environment effects on structural neuroimaging endophenotype for bipolar disorder: a novel molecular approach
por: Hu, Bo, et al.
Publicado: (2022)

In memory of Professor Iain Wilkinson: cognitive and neuroimaging endophenotypes in a consanguineous schizophrenia multiplex family
por: Wilkinson, Iain D., et al.
Publicado: (2023)

Neuroimaging-AI Endophenotypes of Brain Diseases in the General Population: Towards a Dimensional System of Vulnerability
por: Wen, Junhao, et al.
Publicado: (2023)

Marked gender differences in progression of mild cognitive impairment over 8 years
por: Lin, Katherine A., et al.
Publicado: (2015)

Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
por: Wittenberg, Raphael, et al.
Publicado: (2019)

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment
por: Pink, Anna, et al.
Publicado: (2021)

Introduction to special edition, “State of the Field: Advances in Neuroimaging from the 2016 Alzheimer's Imaging Consortium”
por: Mormino, Elizabeth C., et al.
Publicado: (2016)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Connecting Professional Practice and Technology at the Bedside: Nurses' Beliefs about Using an Electronic Health Record and Their Ability to Incorporate Professional and Patient-Centered Nursing Activities in Patient Care
por: Gomes, Melissa, et al.
Publicado: (2016)

Editorial: Endophenotypes for Schizophrenia and Mood Disorders: Implications from Genetic, Biochemical, Cognitive, Behavioral, and Neuroimaging Studies
por: Misiak, Błażej, et al.
Publicado: (2016)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
por: Lussier, Firoza Z., et al.
Publicado: (2020)

Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
por: Wang, Guoqiao, et al.
Publicado: (2015)

Kinect Project: People with dementia or mild cognitive impairment learning to play group motion-based games
por: Dove, Erica, et al.
Publicado: (2019)

A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT
por: Fortier, Mélanie, et al.
Publicado: (2020)

Mild cognitive impairment among rural‐dwelling older adults in China: A community‐based study
por: Cong, Lin, et al.
Publicado: (2022)

The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
por: Dickerson, Bradford C., et al.
Publicado: (2009)

A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol
por: Saito, Satoshi, et al.
Publicado: (2016)

Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent training
por: Teixeira, Camila Vieira Ligo, et al.
Publicado: (2018)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

The validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment
por: Ozer, Seline, et al.
Publicado: (2016)

Combined mnemonic strategy training and high-definition transcranial direct current stimulation for memory deficits in mild cognitive impairment
por: Hampstead, Benjamin M., et al.
Publicado: (2017)

Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q6l5v4bbqk0d1uc99th5gp7giu